Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates.
Machulkin AE, Skvortsov DA, Ivanenkov YA, Ber AP, Kavalchuk MV, Aladinskaya AV, Uspenskaya AA, Shafikov RR, Plotnikova EA, Yakubovskaya RI, Nimenko EA, Zyk NU, Beloglazkina EK, Zyk NV, Koteliansky VE, Majouga AG. Machulkin AE, et al. Among authors: zyk nu, zyk nv. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2229-2235. doi: 10.1016/j.bmcl.2019.06.035. Epub 2019 Jun 20. Bioorg Med Chem Lett. 2019. PMID: 31248772
Cleavage of the C-S bond with the formation of a binuclear copper complex with 2-thiolato-3-phenyl-5-(pyridine-2-ylmethylene)-3,5-dihydro-4H-imidazole-4-one. A new mimic of the active site of N2O reductase.
Majouga AG, Beloglazkina EK, Moiseeva AA, Shilova OV, Manzheliy EA, Lebedeva MA, Davies ES, Khlobystov AN, Zyk NV. Majouga AG, et al. Among authors: zyk nv. Dalton Trans. 2013 May 14;42(18):6290-3. doi: 10.1039/c3dt50422k. Dalton Trans. 2013. PMID: 23525195
Mixed valence copper(I,II) binuclear complexes with unexpected structure: synthesis, biological properties and anticancer activity.
Majouga AG, Zvereva MI, Rubtsova MP, Skvortsov DA, Mironov AV, Azhibek DM, Krasnovskaya OO, Gerasimov VM, Udina AV, Vorozhtsov NI, Beloglazkina EK, Agron L, Mikhina LV, Tretyakova AV, Zyk NV, Zefirov NS, Kabanov AV, Dontsova OA. Majouga AG, et al. Among authors: zyk nv. J Med Chem. 2014 Jul 24;57(14):6252-8. doi: 10.1021/jm500154f. Epub 2014 Jul 8. J Med Chem. 2014. PMID: 24950478
Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors.
Ivanenkov YA, Vasilevski SV, Beloglazkina EK, Kukushkin ME, Machulkin AE, Veselov MS, Chufarova NV, Chernyaginab ES, Vanzcool AS, Zyk NV, Skvortsov DA, Khutornenko AA, Rusanov AL, Tonevitsky AG, Dontsova OA, Majouga AG. Ivanenkov YA, et al. Among authors: zyk nv. Bioorg Med Chem Lett. 2015 Jan 15;25(2):404-9. doi: 10.1016/j.bmcl.2014.09.070. Epub 2014 Oct 2. Bioorg Med Chem Lett. 2015. PMID: 25479770
Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives.
Ivanenkov YA, Veselov MS, Rezekin IG, Skvortsov DA, Sandulenko YB, Polyakova MV, Bezrukov DS, Vasilevsky SV, Kukushkin ME, Moiseeva AA, Finko AV, Koteliansky VE, Klyachko NL, Filatova LA, Beloglazkina EK, Zyk NV, Majouga AG. Ivanenkov YA, et al. Among authors: zyk nv. Bioorg Med Chem. 2016 Feb 15;24(4):802-11. doi: 10.1016/j.bmc.2015.12.050. Epub 2016 Jan 2. Bioorg Med Chem. 2016. PMID: 26780833
Thiourea Modified Doxorubicin: A Perspective pH-Sensitive Prodrug.
Krasnovskaya OO, Malinnikov VM, Dashkova NS, Gerasimov VM, Grishina IV, Kireev II, Lavrushkina SV, Panchenko PA, Zakharko MA, Ignatov PA, Fedorova OA, Jonusauskas G, Skvortsov DA, Kovalev SS, Beloglazkina EK, Zyk NV, Majouga AG. Krasnovskaya OO, et al. Among authors: zyk nv. Bioconjug Chem. 2019 Mar 20;30(3):741-750. doi: 10.1021/acs.bioconjchem.8b00885. Epub 2019 Feb 13. Bioconjug Chem. 2019. PMID: 30726065
Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.
Ivanenkov YA, Machulkin AE, Garanina AS, Skvortsov DA, Uspenskaya AA, Deyneka EV, Trofimenko AV, Beloglazkina EK, Zyk NV, Koteliansky VE, Bezrukov DS, Aladinskaya AV, Vorobyeva NS, Puchinina MM, Riabykh GK, Sofronova AA, Malyshev AS, Majouga AG. Ivanenkov YA, et al. Among authors: zyk nv. Bioorg Med Chem Lett. 2019 May 15;29(10):1246-1255. doi: 10.1016/j.bmcl.2019.01.040. Epub 2019 Feb 1. Bioorg Med Chem Lett. 2019. PMID: 30904185
Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246-1255].
Ivanenkov YA, Machulkin AE, Garanina AS, Skvortsov DA, Uspenskaya AA, Deyneka EV, Trofimenko AV, Beloglazkina EK, Zyk NV, Koteliansky VE, Bezrukov DS, Aladinskaya AV, Vorobyeva NS, Puchinina MM, Ryabykh GK, Sofronova AA, Malyshev AS, Majouga AG. Ivanenkov YA, et al. Among authors: zyk nv. Bioorg Med Chem Lett. 2019 Jul 1;29(13):1688. doi: 10.1016/j.bmcl.2019.04.038. Epub 2019 May 2. Bioorg Med Chem Lett. 2019. PMID: 31056242 No abstract available.
33 results